Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2255 | 4236 | 40.5 | 78% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
630 | 9614 | NOONAN SYNDROME//COSTELLO SYNDROME//PROTEIN TYROSINE PHOSPHATASE |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1787 | 2415 | PTP1B//PROTEIN TYROSINE PHOSPHATASE//PROTEIN TYROSINE PHOSPHATASE 1B |
14901 | 673 | PROSTATIC ACID PHOSPHATASE//SECT UROL SURG//PROSTATIC PHOSPHATASE |
20516 | 395 | ACP1//PHOSPHOTYROSINE PROTEIN PHOSPHATASE//LMW PTP |
21054 | 374 | TARTRATE RESISTANT ACID PHOSPHATASE//SPECIAL HEMATOL//TARTRATE RESISTANT |
25954 | 220 | PRL 3//PHOSPHATASE OF REGENERATING LIVER 3//PRL 1 |
28974 | 159 | ACYLPHOSPHATASE//ACYLPHOSPHATASE CATALYTIC MECHANISM//ACYLPHOSPHATASE MUTANT |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PTP1B | Author keyword | 133 | 58% | 4% | 152 |
2 | PROTEIN TYROSINE PHOSPHATASE | Author keyword | 127 | 35% | 7% | 295 |
3 | PRL 3 | Author keyword | 116 | 88% | 1% | 56 |
4 | ACP1 | Author keyword | 64 | 79% | 1% | 41 |
5 | PROTEIN TYROSINE PHOSPHATASE 1B | Author keyword | 57 | 49% | 2% | 84 |
6 | PTPIP51 | Author keyword | 45 | 94% | 0% | 16 |
7 | TCPTP | Author keyword | 41 | 85% | 1% | 22 |
8 | ACYLPHOSPHATASE | Author keyword | 40 | 70% | 1% | 33 |
9 | PROTEIN TYROSINE PHOSPHATASES | Author keyword | 37 | 39% | 2% | 74 |
10 | PRL 1 | Author keyword | 34 | 93% | 0% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PTP1B | 133 | 58% | 4% | 152 | Search PTP1B | Search PTP1B |
2 | PROTEIN TYROSINE PHOSPHATASE | 127 | 35% | 7% | 295 | Search PROTEIN+TYROSINE+PHOSPHATASE | Search PROTEIN+TYROSINE+PHOSPHATASE |
3 | PRL 3 | 116 | 88% | 1% | 56 | Search PRL+3 | Search PRL+3 |
4 | ACP1 | 64 | 79% | 1% | 41 | Search ACP1 | Search ACP1 |
5 | PROTEIN TYROSINE PHOSPHATASE 1B | 57 | 49% | 2% | 84 | Search PROTEIN+TYROSINE+PHOSPHATASE+1B | Search PROTEIN+TYROSINE+PHOSPHATASE+1B |
6 | PTPIP51 | 45 | 94% | 0% | 16 | Search PTPIP51 | Search PTPIP51 |
7 | TCPTP | 41 | 85% | 1% | 22 | Search TCPTP | Search TCPTP |
8 | ACYLPHOSPHATASE | 40 | 70% | 1% | 33 | Search ACYLPHOSPHATASE | Search ACYLPHOSPHATASE |
9 | PROTEIN TYROSINE PHOSPHATASES | 37 | 39% | 2% | 74 | Search PROTEIN+TYROSINE+PHOSPHATASES | Search PROTEIN+TYROSINE+PHOSPHATASES |
10 | PRL 1 | 34 | 93% | 0% | 13 | Search PRL+1 | Search PRL+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PTP1B | 105 | 62% | 3% | 109 |
2 | 1B | 88 | 34% | 5% | 214 |
3 | 1B INHIBITORS | 87 | 88% | 1% | 42 |
4 | CRYP ALPHA | 81 | 96% | 1% | 25 |
5 | PTP 1B INHIBITORS | 79 | 94% | 1% | 29 |
6 | SUBSTRATE TRAPPING MUTANTS | 73 | 89% | 1% | 33 |
7 | DEP 1 | 70 | 89% | 1% | 32 |
8 | REGENERATING LIVER 3 | 69 | 96% | 1% | 22 |
9 | PRL 3 PHOSPHATASE | 69 | 93% | 1% | 26 |
10 | ACP1 | 62 | 90% | 1% | 27 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Inside the human cancer tyrosine phosphatome | 2011 | 133 | 182 | 58% |
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery | 2007 | 238 | 69 | 78% |
PTP1B and TCPTP - nonredundant phosphatases in insulin signaling and glucose homeostasis | 2013 | 33 | 132 | 66% |
Protein tyrosine phosphatases: from genes, to function, to disease | 2006 | 618 | 126 | 33% |
Protein tyrosine phosphatases - from housekeeping enzymes to master regulators of signal transduction | 2013 | 55 | 219 | 37% |
Protein tyrosine phosphatases in the human genome | 2004 | 929 | 69 | 26% |
PTP1B: a double agent in metabolism and oncogenesis | 2010 | 74 | 85 | 73% |
Small molecule tools for functional interrogation of protein tyrosine phosphatases | 2013 | 33 | 125 | 50% |
Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control | 2011 | 46 | 42 | 76% |
Protein-tyrosine phosphatases and cancer | 2006 | 283 | 154 | 51% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SPECIAL HEMATOL | 14 | 51% | 0.5% | 20 |
2 | BIOPATHOL IMAGING DIAGNOST | 13 | 39% | 0.6% | 27 |
3 | EDMOND H FI ER SIGNAL TRANSDUCT | 9 | 38% | 0.5% | 20 |
4 | BIOPATHOL HUMAN POPULAT ENVIRONM PATHOL | 9 | 67% | 0.2% | 8 |
5 | SECT UROL SURG | 5 | 35% | 0.3% | 12 |
6 | MEDCHEM 1 | 5 | 63% | 0.1% | 5 |
7 | 47R | 4 | 67% | 0.1% | 4 |
8 | MED C6 | 4 | 67% | 0.1% | 4 |
9 | PREVENT SOCIAL PEDIAT | 4 | 38% | 0.2% | 8 |
10 | CHAIR PREVENT SOCIAL PEDIAT | 3 | 45% | 0.1% | 5 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000028907 | NOONAN SYNDROME//COSTELLO SYNDROME//THROMBOSPONDIN 1 |
2 | 0.0000013760 | MIDKINE//PLEIOTROPHIN//HB GAM |
3 | 0.0000012659 | COFFIN LOWRY SYNDROME//ERK5//JNK |
4 | 0.0000010237 | FOCAL ADHESION KINASE//INTEGRIN LINKED KINASE//FAK |
5 | 0.0000009658 | CANTHARIDIN//NORCANTHARIDIN//CIP2A |
6 | 0.0000009475 | X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK |
7 | 0.0000009188 | N PHOSPHORYL AMINO ACID//BIOORGAN PHOSPHORUS CHEM//SERYL HISTIDINE DIPEPTIDE |
8 | 0.0000008031 | VITAMIN K//PHYLLOQUINONE//VITAMIN K2 |
9 | 0.0000007377 | TENASCIN C//TENASCIN//POLYSIALIC ACID |
10 | 0.0000006404 | CHRONIC MYELOID LEUKEMIA//IMATINIB//BCR ABL |